Search Results for:
Sort by: Relevance Date
Coronavirus Aid, Relief, and Economic Security (CARES) Act
Economic support and stimulus bill
No Date
No Date
COVID-19: Resilience, recovery and new reality
Helping Healthcare and Life Sciences organizations work together to meet the unprecedented challenges of a rapidly changing landscape.
No Date
No Date
COVID-19: Telemedicine and tax
As telemedicine accelerates, the need for greater tax clarity and updated guidance relating to virtual healthcare is evident.
No Date
No Date
The critical role of health plans during and after COVID-19
Health plans are seeking to address economic, workforce and remote member challenges during the COVID-19 outbreak; for more
No Date
No Date
The customer experience continuum
Payers must join health systems and pharmaceutical manufacturers in efforts to improve customer experience.
No Date
No Date
Diagnostics: Ramp-up of testing for COVID-19 & beyond
Private labs seeking to restructure or build to deploy COVID-19 testing operations can benefit from KPMG’s rapid start-up approach
No Date
No Date
Don’t open the door to another threat
Although healthcare organizations are focused on fighting COVID-19, the need for ongoing cyber security should not be underestimated.
No Date
No Date
Executive order on ‘Most-Favored-Nation’ drug pricing
An Executive Order directs HHS rulemaking for “most favored nations” pricing for Medicare Part B and D drugs
No Date
No Date
Executive orders on prescription drug costs
Four Executive Orders (EO) described as action to deliver lower prescription drug prices to American Patients.
No Date
No Date
FDA final rule and guidance on importation of prescription drugs
FDA finalized a rule and guidance allowing states to submit prescription drug importation proposals and manufacturers to re-label drugs for importation
No Date
No Date
For guidance on how to align supplies, medical personnel and clinical operations with the different stages of COVID-19
No Date
No Date
Healthcare providers: A break in the clouds
Health systems’ future growth strategies must align with the ways in which COVID-19 has changed healthcare delivery.
No Date
No Date
HIPAA privacy rule proposed modifications
HHS proposed modifying HIPAA rules governing sharing, privacy, and security of personal health information
No Date
No Date
COVID-19 impact on physician compensation
Healthcare provider organizations are facing financial and operational challenges as a result of COVID-19.
No Date
No Date
KPMG Digital Lighthouse: Powering Life Sciences with advanced analytics
The Life Sciences Industry is moving towards a dramatically different future based on a number of market drivers.
No Date
No Date
